Hepatocellular Carcinoma Complicated by Fulminant Type 1 Diabetes Mellitus Shortly After Initiation of Durvalumab Plus Tremelimumab. Usui N, Imai Y, Sugawara K, Uchida Y, et al. Intern Med 2025;64:2143-2147.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Usui N, Imai Y, Sugawara K, Uchida Y, et al. Hepatocellular Carcinoma Complicated by Fulminant Type 1 Diabetes Mellitus Shortly After Initiation of Durvalumab Plus Tremelimumab. Intern Med 2025;64:2143-2147.
PMID: 39721685